199 related articles for article (PubMed ID: 18490076)
1. Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis.
Yang YY; Lee KC; Huang YT; Wang YW; Hou MC; Lee FY; Lin HC; Lee SD
J Hepatol; 2008 Jul; 49(1):25-33. PubMed ID: 18490076
[TBL] [Abstract][Full Text] [Related]
2. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis.
Yang YY; Huang YT; Lee KC; Lee FY; Lee TY; Hou MC; Lin HC; Lee SD
Clin Sci (Lond); 2009 Jan; 116(1):71-9. PubMed ID: 18479249
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide decreases intrahepatic resistance in cirrhotic rats.
Yang YY; Huang YT; Lin HC; Lee FY; Lee KC; Chau GY; Loong CC; Lai CR; Lee SD
Biochem Biophys Res Commun; 2009 Mar; 380(3):666-72. PubMed ID: 19285019
[TBL] [Abstract][Full Text] [Related]
4. The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension.
Lin HC; Yang YY; Tsai TH; Huang CM; Huang YT; Lee FY; Liu TT; Lee SD
J Hepatol; 2011 Jun; 54(6):1145-53. PubMed ID: 21145843
[TBL] [Abstract][Full Text] [Related]
5. Administration of a low dose of sildenafil for 1 week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability.
Lee KC; Yang YY; Huang YT; Lee FY; Hou MC; Lin HC; Lee SD
Clin Sci (Lond); 2010 Apr; 119(1):45-55. PubMed ID: 20132096
[TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome.
Vercelino R; Tieppo J; Dias AS; Marroni CA; Garcia E; Meurer L; Picada JN; Marroni NP
Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):370-6. PubMed ID: 18341514
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hepatic tumour necrosis factor-alpha attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers.
Yang YY; Lee KC; Huang YT; Lee FY; Chau GY; Loong CC; Lin HC; Lee SD
Liver Int; 2009 May; 29(5):678-85. PubMed ID: 19413671
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.
Zhou Q; Hennenberg M; Trebicka J; Jochem K; Leifeld L; Biecker E; Sauerbruch T; Heller J
Gut; 2006 Sep; 55(9):1296-305. PubMed ID: 16492715
[TBL] [Abstract][Full Text] [Related]
9. Nitration of cardiac proteins is associated with abnormal cardiac chronotropic responses in rats with biliary cirrhosis.
Mani AR; Ippolito S; Ollosson R; Moore KP
Hepatology; 2006 Apr; 43(4):847-56. PubMed ID: 16557556
[TBL] [Abstract][Full Text] [Related]
10. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
11. Improvement of portal flow and hepatic microcirculatory tissue flow with N-acetylcysteine in dogs with obstructive jaundice produced by bile duct ligation.
Kigawa G; Nakano H; Kumada K; Kitamura N; Takeuchi S; Hatakeyama T; Yamaguchi M; Nagasaki H; Boudjema K; Jaeck D
Eur J Surg; 2000 Jan; 166(1):77-84. PubMed ID: 10688222
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
[TBL] [Abstract][Full Text] [Related]
13. Evidence against a role for NADPH oxidase modulating hepatic vascular tone in cirrhosis.
Gracia-Sancho J; Laviña B; Rodríguez-Vilarrupla A; Brandes RP; Fernández M; Bosch J; García-Pagán JC
Gastroenterology; 2007 Sep; 133(3):959-66. PubMed ID: 17854599
[TBL] [Abstract][Full Text] [Related]
14. Lipoic acid prevents development of the hyperdynamic circulation in anesthetized rats with biliary cirrhosis.
Marley R; Holt S; Fernando B; Harry D; Anand R; Goodier D; Davies S; Moore K
Hepatology; 1999 May; 29(5):1358-63. PubMed ID: 10216116
[TBL] [Abstract][Full Text] [Related]
15. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
[TBL] [Abstract][Full Text] [Related]
16. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
Biecker E; Trebicka J; Kang A; Hennenberg M; Sauerbruch T; Heller J
Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
[TBL] [Abstract][Full Text] [Related]
17. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic CB1 cannabinoid receptor antagonism on livers of rats with biliary cirrhosis.
Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
Clin Sci (Lond); 2007 May; 112(10):533-42. PubMed ID: 17176248
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic L-NAME on nitrotyrosine expression and renal vascular reactivity in rats with chronic bile-duct ligation.
Alcaraz A; Hernández D; Iyú D; Mota R; Atucha NM; Ortiz AJ; García-Estañ J; Ortiz MC
Clin Sci (Lond); 2008 Jul; 115(2):57-68. PubMed ID: 18184108
[TBL] [Abstract][Full Text] [Related]
20. [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model].
Kim MY; Baik SK; Jang YO; Suk KT; Kim JW; Kim HS; Cho MY; Choi SJ; Um SH; Han KH
Korean J Hepatol; 2008 Jun; 14(2):159-67. PubMed ID: 18617763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
